Carboxyl-terminal and intracellular loop sites for CRF1receptor phosphorylation and β-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses
- 1 July 2007
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 293 (1) , R209-R222
- https://doi.org/10.1152/ajpregu.00099.2006
Abstract
The primary goal was to test the hypothesis that agonist-induced corticotropin-releasing factor type 1 (CRF1) receptor phosphorylation is required for β-arrestins to translocate from cytosol to the cell membrane. We also sought to determine the relative importance to β-arrestin recruitment of motifs in the CRF1receptor carboxyl terminus and third intracellular loop. β-Arrestin-2 translocated significantly more rapidly than β-arrestin-1 to agonist-activated membrane CRF1receptors in multiple cell lines. Although CRF1receptors internalized with agonist treatment, neither arrestin isoform trafficked with the receptor inside the cell, indicating that CRF1receptor-arrestin complexes dissociate at or near the cell membrane. Both arrestin and clathrin-dependent mechanisms were involved in CRF1receptor internalization. To investigate molecular determinants mediating the robust β-arrestin-2-CRF1receptor interaction, mutagenesis was performed to remove potential G protein-coupled receptor kinase phosphorylation sites. Truncating the CRF1receptor carboxyl terminus at serine-386 greatly reduced agonist-dependent phosphorylation but only partially impaired β-arrestin-2 recruitment. Removal of a serine/threonine cluster in the third intracellular loop also significantly reduced CRF1receptor phosphorylation but did not alter β-arrestin-2 recruitment. Phosphorylation was abolished in a CRF1receptor possessing both mutations. Surprisingly, this mutant still recruited β-arrestin-2. These mutations did not alter membrane expression or cAMP signaling of CRF1receptors. Our data reveal the involvement of at least the following two distinct receptor regions in β-arrestin-2 recruitment: 1) a carboxyl-terminal motif in which serine/threonine residues must be phosphorylated and 2) an intracellular loop motif configured by agonist-induced changes in CRF1receptor conformation. Deficient β-arrestin-2-CRF1receptor interactions could contribute to the pathophysiology of affective disorders by inducing excessive CRF1receptor signaling.Keywords
This publication has 52 references indexed in Scilit:
- Differential Responses of Corticotropin-Releasing Hormone Receptor Type 1 Variants to Protein Kinase C PhosphorylationThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Role of the C Terminus in Neuropeptide Y Y Receptor Desensitization and InternalizationMolecular Pharmacology, 2005
- Is Psychopharmacologic "Inoculation" Effective in Preventing Posttraumatic Stress Disorder?The Journal of Clinical Psychiatry, 2005
- Mediation of Corticotropin Releasing Factor Type 1 Receptor Phosphorylation and Desensitization by Protein Kinase C: A Possible Role in Stress AdaptationThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Phosphorylation of Key Serine Residues Is Required for Internalization of the Complement 5a (C5a) Anaphylatoxin Receptor via a β-Arrestin, Dynamin, and Clathrin-dependent PathwayJournal of Biological Chemistry, 2003
- The Association of Arrestin-3 with the Human Lutropin/Choriogonadotropin Receptor Depends Mostly on Receptor Activation Rather than on Receptor PhosphorylationPublished by Elsevier ,2002
- Rapid Agonist-Induced Phosphorylation of the Human CRF Receptor, Type 1: A Potential Mechanism for Homologous DesensitizationBiochemical and Biophysical Research Communications, 2000
- Identification of the G Protein-coupled Receptor Kinase Phosphorylation Sites in the Human β2-Adrenergic ReceptorPublished by Elsevier ,1996
- Homologous desensitization of human corticotropin-releasing factor, receptor in stable transfected mouse fibroblast cellsBrain Research, 1996
- Desensitization of corticotropin-releasing factor receptorsBiochemical and Biophysical Research Communications, 1983